Down-regulation of the microRNA-99 family members in head and neck squamous cell carcinoma.
暂无分享,去创建一个
Dongsheng Yu | Yi Jin | Xiqiang Liu | Cheng Wang | Yi Jin | Zujian Chen | Xiaofeng Zhou | Anxun Wang | Xiaofeng Zhou | Dongsheng Yu | Anxun Wang | I. Mahjabeen | Cheng Wang | Xiqiang Liu | Zujian Chen | Ishrat Mahjabeen | Anxun Wang | Ishrat Mahjabeen
[1] R. Gilbert,et al. Programmed cell death 4 loss increases tumor cell invasion and is regulated by miR-21 in oral squamous cell carcinoma , 2010, Molecular Cancer.
[2] Yi Jin,et al. MicroRNA-138 suppresses epithelial-mesenchymal transition in squamous cell carcinoma cell lines. , 2011, The Biochemical journal.
[3] Derek Y. Chiang,et al. IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage. , 2010, Journal of hepatology.
[4] Iris Barshack,et al. MiRNA Expression in Psoriatic Skin: Reciprocal Regulation of hsa-miR-99a and IGF-1R , 2011, PloS one.
[5] Wei Shi,et al. Comprehensive MicroRNA Profiling for Head and Neck Squamous Cell Carcinomas , 2010, Clinical Cancer Research.
[6] A. Palmieri,et al. MicroRNA Expression Profiling of Oral Carcinoma Identifies New Markers of Tumor Progression , 2010, International journal of immunopathology and pharmacology.
[7] A. Kolokythas,et al. MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells. , 2010, The Biochemical journal.
[8] Y. Okamoto,et al. miR-489 is a tumour-suppressive miRNA target PTPN11 in hypopharyngeal squamous cell carcinoma (HSCC) , 2010, British Journal of Cancer.
[9] Cai-yun Zhou,et al. Reduced miR-100 expression in cervical cancer and precursors and its carcinogenic effect through targeting PLK1 protein. , 2011, European journal of cancer.
[10] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[11] Brock C Christensen,et al. MicroRNA Expression Ratio Is Predictive of Head and Neck Squamous Cell Carcinoma , 2009, Clinical Cancer Research.
[12] Ankit Malhotra,et al. miR-99 family of MicroRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation. , 2011, Cancer research.
[13] C. Croce,et al. MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.
[14] Lu Jiang,et al. MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines. , 2009, Cancer letters.
[15] S. Chiou,et al. miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma. , 2010, Cancer research.
[16] R. Friedrich,et al. Insulin-like growth factor-1 receptor (IGF-1R) in primary and metastatic undifferentiated carcinoma of the head and neck: a possible target of immunotherapy. , 2010, Anticancer research.
[17] S. Kao,et al. Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer. , 2010, Oral diseases.
[18] Shuai Jiang,et al. MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. , 2010, Cancer research.
[19] E. Lalli,et al. Regulation of insulin-like growth factor-mammalian target of rapamycin signaling by microRNA in childhood adrenocortical tumors. , 2010, Cancer research.
[20] D. Wong,et al. Dissecting the Akt/Mammalian Target of Rapamycin Signaling Network: Emerging Results from the Head and Neck Cancer Tissue Array Initiative , 2007, Clinical Cancer Research.
[21] F. Slack,et al. Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.
[22] William Ignace Wei,et al. Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue , 2008, Clinical Cancer Research.
[23] Robert A. Weinberg,et al. A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis , 2009 .
[24] Geoffrey Childs,et al. Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. , 2009, The American journal of pathology.
[25] X. Guan,et al. miR-130b is preferentially upregulated in CD133+ liver cancer stem cells and regulates tumor growth and self-renewal via tumor protein 53-induced nuclear protein 1 , 2009 .
[26] Steven J. M. Jones,et al. Meta-analysis of Colorectal Cancer Gene Expression Profiling Studies Identifies Consistently Reported Candidate Biomarkers , 2008, Cancer Epidemiology Biomarkers & Prevention.
[27] Jianmin Si,et al. MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2 , 2010, Cell Research.
[28] M. Salto‐Tellez,et al. MicroRNA-130b regulates the tumour suppressor RUNX3 in gastric cancer. , 2010, European journal of cancer.
[29] Igor Jurisica,et al. Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma. , 2009, Human molecular genetics.
[30] David Sidransky,et al. MicroRNA alterations in head and neck squamous cell carcinoma , 2008, International journal of cancer.
[31] P. Lara,et al. IGF-1R expression predicts clinical outcome in patients with locally advanced oral squamous cell carcinoma. , 2011, Oral oncology.
[32] I. Ng,et al. miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1. , 2010, Cell stem cell.
[33] C. Mathers,et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.
[34] Domenico Coppola,et al. MicroRNA-155 Is Regulated by the Transforming Growth Factor β/Smad Pathway and Contributes to Epithelial Cell Plasticity by Targeting RhoA , 2008, Molecular and Cellular Biology.
[35] T. Garland,et al. Identification and experimental validation of G protein alpha inhibiting activity polypeptide 2 (GNAI2) as a microRNA-138 target in tongue squamous cell carcinoma , 2011, Human Genetics.
[36] M. Seto,et al. MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. , 2010, Cancer research.
[37] M. Slomiany,et al. Insulin-like growth factor-1 receptor and ligand targeting in head and neck squamous cell carcinoma. , 2007, Cancer letters.
[38] T. Matsumura,et al. Establishment of High and Low Metastasis Cell Lines Derived from a Human Tongue Squamous Cell Carcinoma , 1998, Invasion and Metastasis.
[39] W. Tan,et al. Circulating MicroRNAs, miR‐21, miR‐122, and miR‐223, in patients with hepatocellular carcinoma or chronic hepatitis , 2011, Molecular Carcinogenesis.
[40] Lu Jiang,et al. MicroRNA-222 regulates cell invasion by targeting matrix metalloproteinase 1 (MMP1) and manganese superoxide dismutase 2 (SOD2) in tongue squamous cell carcinoma cell lines. , 2009, Cancer genomics & proteomics.
[41] Steven J. M. Jones,et al. Meta-analysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[42] Yandan Yao,et al. MiR-21 Indicates Poor Prognosis in Tongue Squamous Cell Carcinomas as an Apoptosis Inhibitor , 2009, Clinical Cancer Research.
[43] Martin M Matzuk,et al. A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer. , 2010, Molecular endocrinology.
[44] Lan Xu,et al. miR-21 and miR-31 Converge on TIAM1 to Regulate Migration and Invasion of Colon Carcinoma Cells* , 2010, The Journal of Biological Chemistry.
[45] Hongwei Zhang,et al. miRNA-223 Promotes Gastric Cancer Invasion and Metastasis by Targeting Tumor Suppressor EPB41L3 , 2011, Molecular Cancer Research.
[46] M. Hixon,et al. Development of inhibitors of the IGF-IR/PI3K/Akt/mTOR pathway. , 2010, Reviews on recent clinical trials.
[47] Bhuvanesh Singh,et al. Genetic abnormalities associated with nodal metastasis in head and neck cancer , 2004, Head & neck.
[48] C. von Buchwald,et al. Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study , 2011, British Journal of Cancer.
[49] B. Sjöström,et al. miRNA analysis of formalin-fixed squamous cell carcinomas of the tongue is affected by age of the samples. , 2010, International journal of oncology.
[50] William Kong,et al. Strategies for profiling MicroRNA expression , 2009, Journal of cellular physiology.
[51] J. Zha,et al. Targeting the Insulin-like Growth Factor Receptor-1R Pathway for Cancer Therapy , 2010, Clinical Cancer Research.
[52] A. Kolokythas,et al. MicroRNA‐24 targeting RNA‐binding protein DND1 in tongue squamous cell carcinoma , 2010, FEBS letters.
[53] K. Coombes,et al. miRNA expression profiles in head and neck squamous cell carcinoma and adjacent normal tissue , 2009, Head & neck.
[54] C. Croce,et al. Human Cytomegalovirus Infection Alters the Expression of Cellular MicroRNA Species That Affect Its Replication , 2008, Journal of Virology.